by editor | Dec 21, 2020 | Clinicians, Participants, Researchers
Above: Prof Mike Ernst is a US based investigator to the ASPREE project. Meet Professor Mike Ernst Michael E. Ernst is a clinical professor at the University of Iowa (UI) College of Pharmacy Department of Pharmacy Practice and Science. He is a pharmacist and a...
by editor | Aug 13, 2020 | Clinicians, Participants, Researchers
New analysis identifies potential risk of major GI bleeding in older adults A closer analysis of data from the ASPREE trial provides doctors, for the first time, with information about how much aspirin may increase the risk of gastrointestinal (GI) bleeding in...
by editor | Jul 3, 2020 | Participants
Important information about ASPREE-XT study visits and COVID-19 The ASPREE-XT study team continues to adapt study visit activity in line with government advice. Study visits may be conducted in-person, or via phone calls, depending on restrictions at the...
by editor | Jul 2, 2020 | Clinicians, Media, Participants, Researchers
Statins may prevent heart attacks and strokes but may not prolong life free of disability PRESS RELEASE 2nd JULY 2020 A new observational study shows the first-line cholesterol-lowering drugs known as statins are associated with fewer heart attacks and...
by editor | Jun 4, 2020 | Clinicians, Participants, Researchers
ASPREE-D sub-study finds daily aspirin not protective against late-life depression PRESS RELEASE: 4th June 2020 Taking low-dose aspirin daily does not prevent depression in healthy older adults, according to new findings from researchers at the ASPREE (ASPirin...
Recent Comments